Memory DeclineFIND-AD Aim 2NCT07218120
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
A study testing Financial Incentive and Active Comparator #1 in people with Memory Decline and Healthy Subjects, run by University of Southern California at 1 site in United States.
Trial summary
Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. Read more about this study
- Who is it for?
- Ages 50 years and olderHealthy volunteers can take part
- Conditions the study is for
- Memory Decline, Healthy Subjects
- What is being tested?
- Financial Incentive and Active Comparator #1
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 209 participants
- Where
- 1 siteUnited States
- Study dates
- 9 Jun 2025to 31 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adults aged 50 and over.
- Able to read English or Spansih
- Email access
Who cannot join
- Current dementia diagnosis.
Trial locations and contacts
1 site in 1 country.
United States1 site
Northgate Gonzalez Market
Chula Vista, California, 91919
About this study
Official title: A Randomized Trial of Financial Incentives for In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to assess whether offering small $25 financial incentives can increase enrollment of diverse community members to the Alzheimer's Prevention Trial (APT) Webstudy, a memory concerns registry meant to accelerate clinical trials, relative to non-monetary incentives such as a reusable grocery bag. To do this we will test in-person recruitment efforts at community events and locations, such as Northgate Gonzalez Market locations and local food bank events. We also aim to compare the relative cost of recruiting an additional person to the APT Webstudy.
- Conditions
- Memory Decline, Healthy Subjects
- Being tested
- Financial Incentive, Active Comparator #1
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Financial IncentiveOther
$25 gift card
Active Comparator #1Other
Nominal value gift
| Study group | Role | What they receive |
|---|---|---|
| Financial incentive | Experimental | Participants in this arm will receive a gift card for enrolling in the APT Web Study Receives: Other: Financial Incentive |
| Nominal value gift | Active comparator | Participants in this arm will receive a $0-$2 gift for enrolling in the APT Web Study. Receives: Other: Active Comparator #1 |
What is being measured
The primary outcome is the main question the study is designed to answer.
APT Webstudy Enrollment
Participant enrolled in the APT Webstudy, which includes completion of at least one of two remote cognitive assessments, on the recruitment day.
Measured: Day 1
Secondary outcomes (2)
Completion of both cognitive assessments
Completion of both APT Webstudy cognitive assessments - the CFI and the BRANCH.
Measured: Day 1
Cost per enrollee
Cost per additional enrollee by arm
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Oct 2025
- Study start9 Jun 2025
- Primary completion31 Oct 2025
- Study completion31 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Memory DeclineStudies of the same condition, open and under way.
- More trials run by University of Southern CaliforniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 209 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Southern California
- Sponsor type
- University, hospital or other
- Collaborators
- Vision y Compromiso, Alzheimer's Therapeutic Research Institute
- Responsible party
- Principal investigator, Mireille Jacobson, University of Southern California
- Investigators
- Mireille Jaocbson, PhD, Principal investigator, University of Southern California
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07218120
- Sponsor's protocol ID
- UP-24-01201
- Other IDs
- 964386, 946223
- Acronym
- FIND-AD Aim 2
- Status last verified
- Jun 2025
- First submitted
- 10 Oct 2025
- Last updated
- 15 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Age, Language, Location, Date, Randomization Status, Enrollment Status
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Trial of Financial Incentives for In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
- ClinicalTrials.gov ID
- NCT07218120
- Acronym / sponsor ID
- FIND-AD Aim 2 / UP-24-01201
- Conditions
- Memory Decline, Healthy Subjects
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 209 participants (actual)
- Lead sponsor
- University of Southern CaliforniaUniversity, hospital or other
- Collaborators
- Vision y Compromiso, Alzheimer's Therapeutic Research Institute
- Study start
- 9 Jun 2025 (actual)
- Primary completion
- 31 Oct 2025 (actual)
- Study completion
- 31 Oct 2025 (actual)
- First posted
- 20 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to assess whether offering small $25 financial incentives can increase enrollment of diverse community members to the Alzheimer's Prevention Trial (APT) Webstudy, a memory concerns registry meant to accelerate clinical trials, relative to non-monetary incentives such as a reusable grocery bag. To do this we will test in-person recruitment efforts at community events and locations, such as Northgate Gonzalez Market locations and local food bank events. We also aim to compare the relative cost of recruiting an additional person to the APT Webstudy.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Financial incentive | Experimental | Other: Financial IncentiveParticipants in this arm will receive a gift card for enrolling in the APT Web Study |
| Nominal value gift | Active comparator | Other: Active Comparator #1Participants in this arm will receive a $0-$2 gift for enrolling in the APT Web Study. |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Adults aged 50 and over.
- Able to read English or Spansih
- Email access
Key exclusion criteria (1 listed)
- Current dementia diagnosis.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Financial Incentive$25 gift card | Other | Financial incentive |
| Active Comparator #1Nominal value gift | Other | Nominal value gift |
Primary outcome
APT Webstudy Enrollment
Time frame: Day 1
Participant enrolled in the APT Webstudy, which includes completion of at least one of two remote cognitive assessments, on the recruitment day.
2 secondary outcomes
Completion of both cognitive assessments
Time frame: Day 1
Cost per enrollee
Time frame: Day 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2026.
- Individual participant dataSharing planned: Yes. Age, Language, Location, Date, Randomization Status, Enrollment Status
Related trials for Memory Decline
Not yet recruitingObservational study
Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E)
Mild Cognitive Impairment, Memory Disorders
Recruiting
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
Obstructive Sleep Apnea, Cognitive Decline
Recruiting
Chinese Classics Recitation Training in Subjective Cognitive Decline
Subjective Cognitive Decline (SCD), Subjective Cognitive Decline
Not yet recruiting
Predicting Declines in Attention and Memory During a Prolonged Mental Task
Mental Fatigue, Cognitive Performance
Recruiting
Lifestyle Intervention in the Memory Clinics of General and Academic Hospitals Trial
Lifestyle Intervention, Lifestyle Risk Reduction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mireille Jaocbson, PhD principal investigator
University of Southern California
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Financial Incentive and Active Comparator #1 in people with Memory Decline and Healthy Subjects, run by University of Southern California at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
APT Webstudy Enrollment (time frame: Day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026.